FDA to tighten up on use of American patients' biological material in "hostile countries"

FirstWord Pharma·Jun 19

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA is planning to tighten regulations, possibly in response to concerns over vaccine safety, including reported deaths of children linked to COVID-19 vaccines. However, the specific focus and scope of the regulatory changes are unclear, with some reports mentioning vaccines, while others reference biological material, tobacco, or experimental flu shots. The FDA's actions may be aimed at addressing safety concerns, but the details of the proposed changes and their potential impact are not yet fully defined.

Full coverage

FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots

Fierce Pharma·Dec 1

View original report at FirstWord Pharma ↗

Fetching the latest headlines…

FDA to tighten up on use of American patients' biological material in "hostile countries"

Full coverage

US FDA proposes rule to tighten oversight of foreign tobacco makers

FDA to raise hurdles for vaccines, faulting COVID shots for 10 kids' deaths

Moderna says FDA refuses to review its application for experimental flu shot

What doctors want patients to know about injectable peptides

The FDA Needs to Adjust to the Reality of AI Software

FDA to tighten vaccine rules after memo ties COVID-19 shot to child deaths

FDA links 10 children's deaths to COVID-19 vaccines. Doctors want proof

FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots